KUALA LUMPUR, June 11 -- Taconic Biosciences, a drug discovery animal model solutions provider has announced local West Coast United States production of the immunodeficient CIEA NOG mouse® model.
According to a statement, the CIEA NOG mouse® lacks the T, B and natural killer cells that drive immune response. It is one of the most widely used severely immunocompromised mouse models.
The NOG mouse provides the foundation for Taconic’s extensive specialised models portfolio, which includes a variety of models with specific genetic and tissue modifications for greater precision.
West Coast production addresses the thriving California biomedical community with additional flexibility in planning experiments via multiple weekly deliveries, flexible ordering timelines and reduced transit times for the animals.
NOG mice from this site are also available at Taconic’s EF health standard, a more restrictive health standard, valuable for immunodeficient models.
“Expanding the production of such a critical resource underscores Taconic’s commitment to providing researchers with easy access to the best animal model solutions,” said Taconic vice-president of commercial products, Dr Michael Seiler.
“The CIEA NOG mouse® is one of the most important animal models in the world because it is the foundation of a portfolio aimed at better replicating the human biosystem in an animal model.”
-- BERNAMA
No comments:
Post a Comment